OmniAb, Inc. (OABI)
NASDAQ: OABI · IEX Real-Time Price · USD
4.700
+0.040 (0.86%)
Jul 22, 2024, 10:17 AM EDT - Market open
OmniAb Employees
OmniAb had 106 employees as of December 31, 2023. The number of employees increased by 11 or 11.58% compared to the previous year.
Employees
106
Change (1Y)
11
Growth (1Y)
11.58%
Revenue / Employee
$198,547
Profits / Employee
-$598,868
Market Cap
546.98M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 106 | 11 | 11.58% |
| Dec 31, 2022 | 95 | 21 | 28.38% |
| Dec 31, 2021 | 74 | 4 | 5.71% |
| Dec 31, 2020 | 70 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cross Country Healthcare | 13,131 |
| Canopy Growth | 1,029 |
| Castle Biosciences | 610 |
| Quanterix | 441 |
| PureTech Health | 90 |
| Terns Pharmaceuticals | 66 |
| PepGen | 64 |
| Mereo BioPharma Group | 33 |
OABI News
- 6 weeks ago - OmniAb Announces Publication of Scientific Paper on Heavy Chain-Only Single-Domain Antibody Chicken Platform in the Journal of Immunology - Business Wire
- 2 months ago - OmniAb to Participate in the Jefferies Global Healthcare Conference - Business Wire
- 2 months ago - OmniAb Presents High-Throughput Single B-cell Screening xPloration® Data at the 20th Annual PEGS Boston Summit - Business Wire
- 2 months ago - OmniAb Reports First Quarter 2024 Financial Results and Business Highlights - Business Wire
- 2 months ago - OmniAb to Participate in Five Investor Conferences in May - Business Wire
- 3 months ago - OmniAb to Report First Quarter 2024 Financial Results on May 9 - Business Wire
- 3 months ago - Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics - Accesswire
- 4 months ago - OmniAb Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights - Business Wire